KalVista Pharmaceuticals (KALV) Cash from Financing Activities (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly Cash from Financing Activities of $23.2 million in Q3 2025, up 398.18% quarter-over-quarter from $4.7 million in Q2 2025, and up 673.67% year-over-year from $3.0 million in Q3 2024.
KalVista Pharmaceuticals' Cash from Financing Activities history runs 10 years deep, the most recent figure standing at $23.2 million for Q3 2025.
- In Q3 2025, Cash from Financing Activities rose 673.67% year-over-year to $23.2 million; the TTM figure through Jul 2025 stood at $31.2 million (down 79.7% YoY), while the FY2025 annual figure was $159.7 million, up 5.98% from the prior year.
- Cash from Financing Activities came in at $23.2 million for Q3 2025 at KalVista Pharmaceuticals, up from $4.7 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $210.3 million in Q2 2021 to a low of -$33000.0 in Q2 2023.
- A 5-year average of $25.2 million and a median of $451500.0 in 2021 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities soared 21030700.0% in 2021 and slumped 123.91% in 2023, its largest moves.
- KalVista Pharmaceuticals' Cash from Financing Activities stood at $63000.0 in 2021, then jumped by 166.67% to $168000.0 in 2022, then slipped by 23.81% to $128000.0 in 2023, then jumped by 130.47% to $295000.0 in 2024, then surged by 7767.8% to $23.2 million in 2025.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $23.2 million, $4.7 million, and $295000.0 for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | 23.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 23.21 Mn |
| Jul 31, 2025 | 23.21 Mn |
| Apr 30, 2025 | 4.66 Mn |
| Apr 30, 2025 | 4.66 Mn |
| Oct 31, 2024 | 295,000.00 |
| Oct 31, 2024 | 295,000.00 |
| Jul 31, 2024 | 3.00 Mn |
| Jul 31, 2024 | 3.00 Mn |
| Apr 30, 2024 | 150.10 Mn |
| Apr 30, 2024 | 150.10 Mn |
| Jan 31, 2024 | 284,000.00 |
| Jan 31, 2024 | 284,000.00 |
| Oct 31, 2023 | 128,000.00 |
| Oct 31, 2023 | 128,000.00 |
| Jul 31, 2023 | 204,000.00 |
| Jul 31, 2023 | 204,000.00 |
| Apr 30, 2023 | -33,000.00 |
| Apr 30, 2023 | -33,000.00 |
| Jan 31, 2023 | 57.81 Mn |
| Jan 31, 2023 | 57.81 Mn |
| Oct 31, 2022 | 168,000.00 |
| Oct 31, 2022 | 168,000.00 |
| Jul 31, 2022 | 168,000.00 |
| Jul 31, 2022 | 168,000.00 |
| Apr 30, 2022 | 138,000.00 |
| Apr 30, 2022 | 138,000.00 |
| Jan 31, 2022 | 772,000.00 |
| Jan 31, 2022 | 772,000.00 |
| Oct 31, 2021 | 63,000.00 |
| Oct 31, 2021 | 63,000.00 |
| Jul 31, 2021 | 608,000.00 |
| Jul 31, 2021 | 608,000.00 |
| Apr 30, 2021 | 210.31 Mn |
| Apr 30, 2021 | 210.31 Mn |
| Jan 31, 2021 | 1.70 Mn |
| Jan 31, 2021 | 1.70 Mn |
| Oct 31, 2020 | 60,000.00 |
| Oct 31, 2020 | 60,000.00 |
| Jul 31, 2020 | 46,000.00 |
| Jul 31, 2020 | 46,000.00 |
| Apr 30, 2020 | 1,000.00 |
| Apr 30, 2020 | 1,000.00 |
| Jan 31, 2020 | 45,000.00 |
| Jan 31, 2020 | 45,000.00 |
| Oct 31, 2019 | 138,000.00 |
| Oct 31, 2019 | 138,000.00 |
| Jul 31, 2019 | 11.40 Mn |
| Jul 31, 2019 | 11.40 Mn |
| Apr 30, 2019 | 155,000.00 |
| Apr 30, 2019 | 155,000.00 |
| Jan 31, 2019 | 56,000.00 |
| Jan 31, 2019 | 56,000.00 |
| Oct 31, 2018 | 82.78 Mn |
| Oct 31, 2018 | 82.78 Mn |
| Jul 31, 2018 | 4.95 Mn |
| Jul 31, 2018 | 4.95 Mn |
| Apr 30, 2018 | -13,000.00 |
| Apr 30, 2018 | -13,000.00 |
| Jan 31, 2018 | -52,000.00 |
| Jan 31, 2018 | -52,000.00 |
| Dec 31, 2015 | 6,000.00 |
| Dec 31, 2015 | 6,000.00 |
| Sep 30, 2015 | -176,000.00 |
| Sep 30, 2015 | -176,000.00 |
| Jun 30, 2015 | 68.72 Mn |
| Jun 30, 2015 | 68.72 Mn |
| Mar 31, 2015 | 3.51 Mn |
| Mar 31, 2015 | 3.51 Mn |
| Sep 30, 2014 | 5.38 Mn |
| Sep 30, 2014 | 5.38 Mn |
| Jun 30, 2014 | -87,000.00 |
| Jun 30, 2014 | -87,000.00 |
| Mar 31, 2014 | 1.25 Mn |
| Mar 31, 2014 | 1.25 Mn |